6 results
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... #Pharm #EM #IM ... #Cardiology #Afib
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC ... #Table #Replacement
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
- Bleeding risk ... due to use of DOAC ... derick_gabel via ACCP Cardiology ... Triple #therapy #anticoagulation ... #management #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC ... Stable patients ... Anticoagulation ... one post op Cardiology ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... Delivery • Stable ... are relatively common ... suggest prophylactic anticoagulation ... #cardiology #treatment
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Endocrinopathies Most Common ... cardiovascular risk ... typically needed • DOACs ... AFib #diagnosis #management ... #cardiology